MAPT and Alzheimer disease: Overexpression of bridging integrator 1 promotes the release of tau-enriched EVs from microglia, and contributes to exacerbate tau pathology in P301S tau transgenic PS19 mice, thus promoting the spread of AD-related tau pathology (Crotti et al., 2019).